Panion & Bf Biotech Inc. (TPE:1760)

Panion & Bf Biotech Revenue

Panion & Bf Biotech had revenue of 511.84M TWD in the quarter ending June 30, 2026, with 1.60% growth. This brings the company's total for the last twelve months to 2.11B, up 4.99% year-over-year. In the year 2025, Panion & Bf Biotech had annual revenue of 2.06B with 1.66% growth. That makes Panion & Bf Biotech the 25,988th largest company in the world by revenue and 1,178th in Taiwan.

• Revenue (ttm): 2.11B
• Revenue Growth: +4.99%
• P/S Ratio: 2.15
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.53B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Taiwan Business Group 1.96B 94.4%
• Business Groups in Mainland China, Hong Kong and Macao 116.11M 5.6%

By Geography

Chart

• Taiwan 1.48B 71.6%
• United States 446.64M 21.6%
• Mainland China, Hong Kong and Macao 123.16M 6.0%
• South Korea 8.51M 0.4%
• Other Countries 6.79M 0.3%

Fiscal year ended Dec 31, 2025 See the full Panion & Bf Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.06B	33.75M	1.66%
Dec 31, 2024	2.03B	147.77M	7.85%
Dec 31, 2023	1.88B	-516.77M	-21.54%
Dec 31, 2022	2.40B	497.44M	26.16%
Dec 31, 2021	1.90B	332.57M	21.20%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error